TY  - JOUR
T1  - SEnsitive troponin i assay in patients with suspected acute coronary syndrome
AU  - Clough JD, Martin SS, Cope MW
Y1  - 2011/08/03
N1  - 10.1001/jama.2011.1061
JO  - JAMA
SP  - 488
EP  - 489
VL  - 306
IS  - 5
N2  - 
One surprising finding was a modest increase in use of recommended therapies in patients with plasma troponin concentrations of 0.05 to 0.19 ng/mL during the implementation phase, which would be expected to result in reduced events. In fact, revascularization rates were stable despite more than a doubling in coronary angiography. Aspirin, β-blocker, and angiotensin-converting enzyme inhibitor use did not differ between the phases. Although more statins were prescribed at discharge in the implementation phase, a similar difference was present on admission, suggesting possible baseline differences between these nonrandomized samples.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2011.1061
UR  - http://dx.doi.org/10.1001/jama.2011.1061
ER  -